First Horizon Advisors, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

First Horizon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$45.8 - $85.4 $183 - $341	4 New	4 $0
Q1 2022 May 10, 2022	SELL	$62.2 - $84.4 $248 - $337	-4 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$73.71 - $87.86 $294 - $351	4 New	4 $0
Q3 2020 Nov 12, 2020	SELL	$72.98 - $90.0 $10,363 - $12,780	-142 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$33.8 - $62.9 $4,799 - $8,931	142 New	142 $6,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.